A Phase 1 First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of ABBV-623 and ABBV-992 in Subjects With B-cell Malignancies


Demirkan F. (Executive), Tunçok Y., Gökmen A. N.

Industrial Organizations of Other Countries Supported Project, 2021 - 2023

  • Project Type: Industrial Organizations of Other Countries Supported Project
  • Begin Date: June 2021
  • End Date: January 2023